Purchase Order SPE2DP25P0666
- Not listed
- This federal contract award, valued at $58,219.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of Dantrolene Sodium F medication. The contract has a total small business set-aside designation. The original solicitation, which was posted on March 27, 2025 and had a due date of April 2, 2025, requested the procurement of 33 units of Dantrolene Sodium F medication across 11 line...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order contract valued at $10,585.32 to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250 mg vials. The contract, awarded on August 18, 2025, with an ultimate completion date of August 21, 2025, was issued without set-aside designation under firm fixed-price terms. Performance will take place in Westwood, New Jersey. This delivery order is issued under Eagle Pharmaceuticals' existing Federal...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex 250 mg vials, a critical injectable medication used to treat and prevent malignant hyperthermia. The contract has a ceiling value of $7,056.88 and an ultimate completion date of May 1, 2025. Eagle Pharmaceuticals holds a significant Federal Supply Schedule (FSS)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,292.66 firm fixed-price delivery order is for the supply of dantrolene sodium powder, a medication used to treat malignant hyperthermia. The contract has an ultimate completion date of April 18, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,421.76 for Ryanodex 250 mg vials on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order is unclassified and carries no set-aside designation, reflecting competitive procurement. The award is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical...
- The Defense Logistics Agency awarded a $127,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for epinephrine injectable solution. The prime contractor will provide 10,000 vials of 1 mg/10 ml epinephrine under the contract, which was awarded to support medical readiness programs of the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early September 2023. No subcontractors or set aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 1, 2025, for the supply of Ryanodex 250mg vials valued at $61,006.72. The contract, which is not set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 21, 2025. This delivery order falls under the Medical Supply Chain division of the Department of Defense, reflecting the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,996.40 for epinephrine 0.3 mg auto-injector (2-pack) on July 31, 2025, with completion targeted for August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a critical pharmaceutical supply need within the federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a delivery order with a firm fixed price of $1,678.60 and a completion date of July 8, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications...
The U.S. Department of Defense, through its Medical Supply Chain division, awarded a firm fixed price purchase order valued at $10,585.32 to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F, with performance expected to conclude by September 19, 2025. This contract is designated as a Total Small Business set-aside and was awarded on September 4, 2025, with work to be performed in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in Woodcliff Lake, New Jersey, has been registered in the System for Award Management since January 2016 and regularly supplies critical injectable medications to federal agencies, particularly the Department of Defense and Department of Veterans Affairs. This purchase order supports the Department of Defense's medical readiness initiatives by procuring specialized pharmaceutical products for military medical supply chains. Eagle Pharmaceuticals' primary focus on high-risk patient population medications, including malignant hyperthermia treatments, positions the company as a critical supplier within the federal healthcare infrastructure. The company's existing Federal Supply Schedule contract with the VA, valued at $30.9 million through January 2029, demonstrates its established role in providing essential pharmaceutical products across multiple federal agencies and supporting regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/4/25 |